<DOC>
	<DOCNO>NCT00886964</DOCNO>
	<brief_summary>The purpose study : - To evaluate prevalence protective hepatitis B antibody compare intradermal ( ID ) intramuscular ( IM ) route antiHbsAb negative HIV infect child treat highly active antiretroviral therapy ( HAART ) - To revaccinate HBV vaccine child n't protective HBV Ab</brief_summary>
	<brief_title>Hepatitis B Vaccination ( HBV ) HIV Infected Children</brief_title>
	<detailed_description>Hepatitis B virus ( HBV ) HIV share route transmission co-infection . The prevalence co-infection 8.7 % Thai adult [ 1 , 2 ] 12.1 % African HIV vertically transmit child [ 3 ] . Occurrence HBV effect treatment due medication , lamivudine , tenofovir , emtricitabine entecavir , anti HIV medication . HBV cause chronic liver disease , cirrhosis hepatocellular carcinoma . In Thailand , routine HBV vaccination program start since 1992 . Few report severe immune compromise HIV child show lose expect preventive measles hepatitis B antibody history schedule vaccination even immune recovery HAART [ 4 , 5 ] . Limited data prevalence protective hepatitis B antibody response immune recovery Thai HIV infect child treat highly active antiretroviral therapy . In addition , HBV revaccination group child consider [ 6 ] . The response HBV revaccination intramuscularly ( IM ) 0 , 2 6 month 63 HIV child show response rate 17.4 , 82.5 , 92.1 % 2 , 6 7 month respectively [ 6 ] . Protective anti-HBs show majority non-responders IM HBV vaccine health care worker [ 21/23 ( 91.3 % ) ] two dos intradermal route ( ID ) [ 7 ] . We hypothesize see fast high response antiHBs first dose ID compare IM anti HBsAb negative HIV infect child . No randomized control trial compare antibody response IM ID route HIV child immune recovery . The benefit trial would decrease vaccine cost resourced limited country .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>HIV infected individual Age 118 year Current CD4 within 6 month ≥ 15 % ≥ 200 cells/ml child age ≥ 6 year Signed write informed consent Negative HBs Ag , antiHBs , antiHBc screen visit Active AIDS Active opportunistic infection Platelet &lt; 50,000/ mm3 screen visit History hypersensitivity HBV vaccine Using oral steroid immunosuppressive drug</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>HBV vaccine</keyword>
	<keyword>HIV child</keyword>
	<keyword>immune recovery</keyword>
	<keyword>HBV antibody</keyword>
	<keyword>Intradermal</keyword>
	<keyword>Intramuscular</keyword>
	<keyword>antibody response HBV vaccine</keyword>
	<keyword>treatment experience</keyword>
</DOC>